EUCLISES PHARMACEUTICALS

euclises-pharmaceuticals-logo

Euclises Pharmaceuticals, Inc is developing novel pain and cancer medications that offer superior safety margins compared to existing drugs. The company is based on new inventions from Dr. John Talley, the most accomplished medicinal chemist in the world. Dr. Talley previously invented Celebrex and seven other approved drugs. New compounds from Euclises will offer both improved efficacy and safety relative to existing therapies. Euclises is located at the BioGenerator Accelerator Labs.

#People #Financial #Website #More

EUCLISES PHARMACEUTICALS

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2011-10-01

Address:
St Louis, Missouri, United States

Country:
United States

Website Url:
http://www.euclises.com

Total Employee:
1+

Status:
Active

Contact:
314-604-2850

Total Funding:
5.43 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag



Current Advisors List

craig-herron_image

Craig Herron Board Observer @ Euclises Pharmaceuticals
Board_observer

raj-devraj_image

Raj Devraj Board Director @ Euclises Pharmaceuticals
Board_member
2015-01-01

robert-beardsley_image

Robert Beardsley Member, Board of Directors @ Euclises Pharmaceuticals
Board_member
2014-03-01

Current Employees Featured

bobby-sandage_image

Bobby Sandage
Bobby Sandage President & CEO @ Euclises Pharmaceuticals
President & CEO
2015-01-01

not_available_image

George H. Capps
George H. Capps Director of Business Development @ Euclises Pharmaceuticals
Director of Business Development

not_available_image

Kathleen Larrimer Beckmann
Kathleen Larrimer Beckmann CFO @ Euclises Pharmaceuticals
CFO

not_available_image

John Talley
John Talley Chief Scientific Officer @ Euclises Pharmaceuticals
Chief Scientific Officer

Founder


not_available_image

Randall Weiss

Investors List

st-louis-arch-angels_image

St. Louis Arch Angels

St. Louis Arch Angels investment in Venture Round - Euclises Pharmaceuticals

argonautic-ventures_image

Argonautic Ventures

Argonautic Ventures investment in Venture Round - Euclises Pharmaceuticals

iselectfund_image

iSELECT FUND

iSELECT FUND investment in Venture Round - Euclises Pharmaceuticals

cultivation-capital_image

Cultivation Capital

Cultivation Capital investment in Venture Round - Euclises Pharmaceuticals

cultivation-capital_image

Cultivation Capital

Cultivation Capital investment in Venture Round - Euclises Pharmaceuticals

helix-fund_image

Helix Fund

Helix Fund investment in Venture Round - Euclises Pharmaceuticals

abc-laboratories_image

ABC Laboratories

ABC Laboratories investment in Venture Round - Euclises Pharmaceuticals

st-louis-arch-angels_image

St. Louis Arch Angels

St. Louis Arch Angels investment in Venture Round - Euclises Pharmaceuticals

cultivation-capital_image

Cultivation Capital

Cultivation Capital investment in Venture Round - Euclises Pharmaceuticals

missouri-technology-corporation_image

Missouri Technology Corporation

Missouri Technology Corporation investment in Venture Round - Euclises Pharmaceuticals

Official Site Inspections

http://www.euclises.com

  • Host name: 151.101.2.159
  • IP address: 151.101.2.159
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Euclises Pharmaceuticals" on Search Engine